3 drug dose - IDA

DRUG3 trials

Sponsors

Washington University School of Medicine

Conditions

ImpetigoLymphatic FilariasesLymphatic FilariasisScabiesSoil Transmitted Helminths

Unknown Phase

Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis

CompletedNCT02899936

Washington University School of MedicineLymphatic Filariasis

Start: 2016-07-31End: 2018-05-31Updated: 2020-12-31

Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji

CompletedNCT03177993

Washington University School of MedicineImpetigo, Lymphatic Filariases, Scabies +1

Start: 2017-07-13End: 2019-10-24Updated: 2020-12-31

Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis

CompletedNCT03352206

Washington University School of MedicineLymphatic Filariases

Start: 2017-10-18End: 2019-11-01Updated: 2020-12-31

Related Papers

Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.

2022-05-0620 citations

Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial

PLoS neglected tropical diseases2022-02-0926 citations

Community control strategies for scabies: A cluster randomised noninferiority trial

PLoS Medicine2021-11-1016 citations

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia

PLoS neglected tropical diseases2021-03-2924 citations

Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial

Clinical Infectious Diseases2021-03-1519 citations

The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study

PLoS Medicine2019-06-2491 citations